Cardiol Therapeutics Inc. (CRDL) stock
CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.86−0.02 (-2.28%)
Close on Nov 20, 2026Market cap $86.48MP/E –Yield –
Cardiol Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Cardiol Therapeutics's price to sales ratio was 396.3× on Feb 28, 2023.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Feb 28, 2023 | 396.3× | +17.6 |
| 2022 | Dec 30, 2022 | 378.7× | – |
See a number that looks wrong?